NCT00698789 - Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

June 30, 2009

Conditions

Type 2 Diabetes

Interventions

DRUG

INCB019602

5 mg of INCB019602 in AM with placebo administration in PM

DRUG

INCB019602

20 mg in AM with placebo administration in PM

DRUG

INCB019602

5 mg in PM with placebo administration in AM

DRUG

INCB019602

20 mg in PM with placebo administration in AM

DRUG

INCB019602

7.5 mg in PM QoD with placebo administration in AM as well as PM on non-active dose days

DRUG

Placebo

Placebo administration in AM or PM depending on treatment arm dosing regimen.

DRUG

Metformin

Stable dose metformin monotherapy

Trial Locations (22)

28211

Charlotte

33709

St. Petersburg

48126

Dearborn

63110

St Louis

66216

Shawnee Mission

68154

Omaha

71101

Shreveport

73103

Oklahoma City

78229

San Antonio

80909

Colorado Springs

85029

Phoenix

85705

Tucson

90723

Paramount

91911

Chula Vista

92117

San Diego

92691

Mission Viejo

92701

Santa Ana

92780

Tustin

92869

Orange

Unknown

Los Angeles

07202

Elizabeth

02914

East Providence